Market Cap

ResMed Inc. Market Capitalization:

$31.33 Billion

USD as of Jan. 1, 2023

business ResMed Inc. Company Profile

ResMed Inc. Main Stock Listing

show_chart NYSE: RMD

Market Capitalization History of ResMed Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Medical Instruments & Supplies
Company Market Cap (USD)
Intuitive Surgical, Inc. $93.87 B
EssilorLuxottica SA $82.37 B
Becton, Dickinson and Company $72.82 B
Alcon Inc. $34.14 B
HOYA Corp $33.01 B
Sector: Healthcare
Company Market Cap (USD)
UnitedHealth Group $495.37 B
Johnson & Johnson $461.85 B
Lilly $347.61 B
Novo Nordisk $304.61 B
Pfizer $287.63 B

Yearly evolution of ResMed Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2023 $31.33 B -6.43%
Jan. 1, 2022 $33.48 B 13.41%
Jan. 1, 2021 $29.52 B 26.80%
Jan. 1, 2020 $23.28 B 67.04%
Jan. 1, 2019 $13.94 B -5.58%
Jan. 1, 2018 $14.76 B 49.23%
Jan. 1, 2017 $9.89 B 19.12%
Jan. 1, 2016 $8.30 B -9.24%
Jan. 1, 2015 $9.15 B 43.25%
Jan. 1, 2014 $6.39 B -0.43%
Jan. 1, 2013 $6.42 B 50.88%
Jan. 1, 2012 $4.25 B -7.81%
Jan. 1, 2011 $4.61 B 23.15%
Jan. 1, 2010 $3.75 B 28.17%
Jan. 1, 2009 $2.92 B -14.10%
Jan. 1, 2008 $3.40 B -11.66%
Jan. 1, 2007 $3.85 B 33.32%
Jan. 1, 2006 $2.89 B 53.76%
Jan. 1, 2005 $1.88 B 16.46%
Jan. 1, 2004 $1.61 B 32.88%
Jan. 1, 2003 $1.21 B -22.91%
Jan. 1, 2002 $1.57 B 2.38%
Jan. 1, 2001 $1.54 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

ResMed Inc. Categories

United States languages Healthcare languages Medical Instruments & Supplies
United States Healthcare United States Medical Instruments & Supplies

Stocks & Indices

ResMed Inc. has the following listings and related stock indices.


Stock: NYSE: RMD

Stock: BMV: RMD

Stock: Bovespa: R1MD34

Stock: FSX: RMEA

Stock: OTC: RSMDF

Stock: ASX: RMD

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.